MB, Levis & Associates’s Synovus SNV Stock Holding History
Bought
Maintained
Sold
Other funds holding SNV
SF
SAM
MB, Levis & Associates's SNV Position: Q1 2024 in Review
MB, Levis & Associates sold out of Synovus (SNV) in Q1 2024, closing a stake of 1,353 shares — an estimated $50.9K sold.
MB, Levis & Associates first reported a position in SNV in Q4 2022 and held it in 5 quarters. The position peaked at $50.9K in Q4 2023. 408 funds tracked by Wall St. Rank hold SNV as of Q1 2024.
- MB, Levis & Associates reported no remaining Synovus position as of Q1 2024 after selling out during the quarter.
- MB, Levis & Associates sold 1,353 Synovus shares in Q1 2024, an estimated $50.9K.
- MB, Levis & Associates first reported a position in Synovus in Q4 2022 and held it in 5 quarters.
- MB, Levis & Associates's Synovus position peaked at $50.9K in Q4 2023.
- 408 funds tracked by Wall St. Rank held Synovus as of Q1 2024.
Based on MB, Levis & Associates's 13F filing for Q1 2024, filed 7 May 2025.